Inhibition of α-globin gene expression by RNAi

Biochemical and Biophysical Research Communications

Volumn 369, Issue 3, 2008, Pages 935-938

  Sarakul, Orawan ^a   Vattanaviboon, Phantip ^a   Wilairat, Prapon ^b   Fucharoen, Suthat ^c   Abe, Yasunobu ^d   Muta, Koichiro ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Mahidol University   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Globin; Erythroid precursor cell; RNAi; siRNA; Thalassemia

Indexed keywords

ALPHA GLOBIN; LIPOFECTAMINE; MESSENGER RNA; SMALL INTERFERING RNA;

5' UNTRANSLATED REGION; ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; ERYTHROID CELL; EXON; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA INTERFERENCE;

APOPTOSIS; CELL DIFFERENTIATION; CELL SURVIVAL; ERYTHROID CELLS; EXONS; GENE EXPRESSION; GLOBINS; HEMOGLOBINS; HUMANS; LIPIDS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 41149164585     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.02.124     Document Type: Article

References (21)

1. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
2. Montgomery M.K., Xu S., and Fire A. RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 95 (1998) 15502-15507
3. Scherr M., Steinmann D., and Eder M. RNA interference (RNAi) in hematology. Ann. Hematol. 83 (2004) 1-8
4. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
5. Tijsterman M., and Plasterk R.H. Dicers at RISC; the mechanism of RNAi. Cell 117 (2004) 1-3
6. Fucharoen S., and Winichagoon P. Thalassemia and abnormal hemoglobin. Int. J. Hematol. 76 Suppl. 2 (2002) 83-89
7. Greenberg P.L., Gordeuk V., Issaragrisil S., Siritanaratkul N., Fucharoen S., and Ribeiro R.C. Major hematologic diseases in the developing world-new aspects of diagnosis and management of thalassemia, malarial anemia, and acute leukemia. Hematol. Am. Soc. Hematol. Educ. Program (2001) 479-498
8. Rund D., and Rachmilewitz E. β-Thalassemia. N. Engl. J. Med. 353 (2005) 1135-1146
9. Dykxhoorn D.M., Novina C.D., and Sharp P.A. Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol. 4 (2003) 457-467
10. Elbashir S.M., Lendeckel W., and Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15 (2001) 188-200
11. Muta K., Krantz S.B., Bondurant M.C., and Dai C.H. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood 86 (1995) 572-580
12. Sawada K., Krantz S.B., Dessypris E.N., Koury S.T., and Sawyer S.T. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J. Clin. Invest. 83 (1989) 1701-1709
13. Ohtsuka R., Abe Y., Fujii T., Yamamoto M., Nishimura J., Takayanagi R., and Muta K. Mortalin is a novel mediator of erythropoietin signaling. Eur. J. Haematol. 79 (2007) 114-125
14. Dalby B., Cates S., Harris A., Ohki E.C., Tilkins M.L., Price P.J., and Ciccarone V.C. Advanced transfection with lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods 33 (2004) 95-103
15. Smetanina N.S., Leonova J.Y., Levy N., and Huisman T.H. The α/β and α2/α1-globin mRNA ratios in different forms of α-thalassemia. Biochim. Biophys. Acta 1315 (1996) 188-192
16. Sawada K., Krantz S.B., Kans J.S., Dessypris E.N., Sawyer S., Glick A.D., and Civin C.I. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J. Clin. Invest. 80 (1987) 357-366
17. Brown B.A. Hematology: Principle and Procedures. sixth ed. (1993), Lea & Febiger, Philadelphia
18. Sandy P., Ventura A., and Jacks T. Mammalian RNAi: a practical guide. Biotechniques 39 (2005) 215-224
19. Dave R.S., and Pomerantz R.J. RNA interference: on the road to an alternate therapeutic strategy. Rev. Med. Virol. 13 (2003) 373-385
20. Samakoglu S., Lisowski L., Budak-Alpdogan T., Usachenko Y., Acuto S., Di Marzo R., Maggio A., Zhu P., Tisdale J.F., Riviere I., and Sadelain M. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference. Nat. Biotechnol. 24 (2006) 89-94
21. Chaisue C., Kitcharoen S., Wilairat P., Jetsrisuparb A., Fucharoen G., and Fucharoen S. α/β-Globin mRNA ratio determination by multiplex quantitative real-time reverse transcription-polymerase chain reaction as an indicator of globin gene function. Clin. Biochem. 40 (2007) 1373-1377